Login / Signup

Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.

Laura M WinglerMeredith A SkibaConor McMahonDean P StausAlissa L W KleinhenzCarl-Mikael SuomivuoriNaomi R LatorracaRon O DrorRobert J LefkowitzAndrew C Kruse
Published in: Science (New York, N.Y.) (2020)
Biased agonists of G protein-coupled receptors (GPCRs) preferentially activate a subset of downstream signaling pathways. In this work, we present crystal structures of angiotensin II type 1 receptor (AT1R) (2.7 to 2.9 angstroms) bound to three ligands with divergent bias profiles: the balanced endogenous agonist angiotensin II (AngII) and two strongly β-arrestin-biased analogs. Compared with other ligands, AngII promotes more-substantial rearrangements not only at the bottom of the ligand-binding pocket but also in a key polar network in the receptor core, which forms a sodium-binding site in most GPCRs. Divergences from the family consensus in this region, which appears to act as a biased signaling switch, may predispose the AT1R and certain other GPCRs (such as chemokine receptors) to adopt conformations that are capable of activating β-arrestin but not heterotrimeric Gq protein signaling.
Keyphrases
  • angiotensin ii
  • angiotensin converting enzyme
  • vascular smooth muscle cells
  • signaling pathway
  • molecular docking
  • binding protein
  • epithelial mesenchymal transition
  • amino acid